Cover Image

Rapid detection of ampicillin resistance in Escherichia coli by quantitative mass spectrometry

Early targeted antimicrobial therapy helps saving costs and prevents the spread of antimicrobial resistances including in Escherichia coli, the most frequent gram-negative bacterium causing sepsis. Therefore, rapid susceptibility testing represents the major prerequisite for knowledge-based successf...

Full description

Saved in:
Bibliographic Details
Main Authors: Grundt, Alexander (Author) , Findeisen, Peter (Author) , Miethke, Thomas (Author) , Jäger, Evelyn (Author) , Ahmad-Nejad, Parviz (Author) , Neumaier, Michael (Author)
Format: Article (Journal)
Language:English
Published: May 2012
In: Journal of clinical microbiology
Year: 2012, Volume: 50, Issue: 5, Pages: 1727-1729
ISSN:1098-660X
DOI:10.1128/JCM.00047-12
Online Access:Verlag, Volltext: http://dx.doi.org/10.1128/JCM.00047-12
Verlag, Volltext: http://jcm.asm.org/content/early/2012/02/02/JCM.00047-12
Get full text
Author Notes:A. Grundt, P. Findeisen, T. Miethke, E. Jäger, P. Ahmad-Nejad and M. Neumaier
Description
Summary:Early targeted antimicrobial therapy helps saving costs and prevents the spread of antimicrobial resistances including in Escherichia coli, the most frequent gram-negative bacterium causing sepsis. Therefore, rapid susceptibility testing represents the major prerequisite for knowledge-based successful antimicrobial treatment. To accelerate testing for antibiotic susceptibility, we have developed a new mass spectrometry-based assay for antibiotic susceptibility testing (MAAST). For proof of principle we present an ampicillin susceptibility test for E.coli with a TAT of 90 minutes upon growth detection.
Item Description:Gesehen am 16.07.2018
Physical Description:Online Resource
ISSN:1098-660X
DOI:10.1128/JCM.00047-12

Similar Items